Benjamin F. Edwards & Company’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $117K | Sell |
1,074
-1,045
| -49% | -$123K | ﹤0.01% | 1067 |
|
|
2024
Q1 | $280K | Buy |
2,119
+234
| +12% | +$29.2K | 0.01% | 812 |
|
|
2023
Q4 | $229K | Buy |
1,885
+1,226
| +186% | +$137K | ﹤0.01% | 839 |
|
|
2023
Q3 | $74K | Hold |
659
| – | – | ﹤0.01% | 970 |
|
|
2023
Q2 | $96K | Buy |
659
+10
| +2% | +$1.36K | ﹤0.01% | 917 |
|
|
2023
Q1 | $84K | Hold |
649
| – | – | ﹤0.01% | 959 |
|
|
2022
Q4 | $83K | Buy |
649
+10
| +2% | +$1.16K | ﹤0.01% | 952 |
|
|
2022
Q3 | $67K | Sell |
639
-357
| -36% | -$39.2K | ﹤0.01% | 977 |
|
|
2022
Q2 | $105K | Buy |
996
+53
| +6% | +$6.29K | 0.01% | 848 |
|
|
2022
Q1 | $121K | Buy |
943
+37
| +4% | +$4.46K | 0.01% | 825 |
|
|
2021
Q4 | $112K | Sell |
906
-19
| -2% | -$2.49K | 0.01% | 854 |
|
|
2021
Q3 | $131K | Sell |
925
-51
| -5% | -$7.5K | 0.01% | 789 |
|
|
2021
Q2 | $152K | Sell |
976
-11
| -1% | -$1.78K | 0.01% | 727 |
|
|
2021
Q1 | $153K | Buy |
987
+11
| +1% | +$1.7K | 0.01% | 744 |
|
|
2020
Q4 | $146K | Sell |
976
-75
| -7% | -$10.6K | 0.01% | 724 |
|
|
2020
Q3 | $139K | Sell |
1,051
-51
| -5% | -$6.66K | 0.01% | 677 |
|
|
2020
Q2 | $128K | Sell |
1,102
-232
| -17% | -$26.7K | 0.01% | 673 |
|
|
2020
Q1 | $131K | Sell |
1,334
-86
| -6% | -$11.3K | 0.01% | 619 |
|
|
2019
Q4 | $206K | Buy |
1,420
+103
| +8% | +$14.2K | 0.01% | 586 |
|
|
2019
Q3 | $176K | Sell |
1,317
-133
| -9% | -$17.2K | 0.01% | 590 |
|
|
2019
Q2 | $166K | Sell |
1,450
-29
| -2% | -$3.4K | 0.01% | 575 |
|
|
2019
Q1 | $183K | Sell |
1,479
-232
| -14% | -$26.4K | 0.02% | 522 |
|
|
2018
Q4 | $172K | Sell |
1,711
-649
| -28% | -$73K | 0.02% | 527 |
|
|
2018
Q3 | $301K | Sell |
2,360
-854
| -27% | -$102K | 0.03% | 433 |
|
|
2018
Q2 | $348K | Buy |
3,214
+21
| +0.7% | +$2.29K | 0.03% | 393 |
|
|
2018
Q1 | $338K | Buy |
3,193
+113
| +4% | +$13.1K | 0.03% | 386 |
|
|
2017
Q4 | $361K | Buy |
3,080
+1,090
| +55% | +$123K | 0.04% | 365 |
|
|
2017
Q3 | $226K | Buy |
1,990
+487
| +32% | +$56.2K | 0.03% | 434 |
|
|
2017
Q2 | $187K | Buy |
1,503
+1,243
| +478% | +$147K | 0.02% | 450 |
|
|
2017
Q1 | $31K | Hold |
260
| – | – | ﹤0.01% | 779 |
|
|
2016
Q4 | $26K | Buy |
260
+152
| +141% | +$16.3K | ﹤0.01% | 738 |
|
|
2016
Q3 | $14K | Hold |
108
| – | – | ﹤0.01% | 774 |
|
|
2016
Q2 | $13K | Hold |
108
| – | – | ﹤0.01% | 747 |
|
|
2016
Q1 | $11K | Hold |
108
| – | – | ﹤0.01% | 798 |
|
|
2015
Q4 | $11K | Hold |
108
| – | – | ﹤0.01% | 827 |
|
|
2015
Q3 | $10K | Hold |
108
| – | – | ﹤0.01% | 877 |
|
|
2015
Q2 | $11K | Hold |
108
| – | – | ﹤0.01% | 917 |
|
|
2015
Q1 | $12K | Buy |
108
+62
| +135% | +$7.07K | ﹤0.01% | 868 |
|
|
2014
Q4 | $5K | Buy |
46
+20
| +77% | +$2.11K | ﹤0.01% | 900 |
|
|
2014
Q3 | $3K | Hold |
26
| – | – | ﹤0.01% | 912 |
|
|
2014
Q2 | $3K | Hold |
26
| – | – | ﹤0.01% | 867 |
|
|
2014
Q1 | $2K | Hold |
26
| – | – | ﹤0.01% | 858 |
|
|
2013
Q4 | $2K | Hold |
26
| – | – | ﹤0.01% | 891 |
|
|
2013
Q3 | $2K | Hold |
26
| – | – | ﹤0.01% | 791 |
|
|
2013
Q2 | $2K | Buy |
+26
| New | +$1.94K | ﹤0.01% | 747 |
|
Other funds holding ZBH
Benjamin F. Edwards & Company's ZBH Position: Q2 2024 in Review
Benjamin F. Edwards & Company reduced its Zimmer Biomet (ZBH) stake by 49% in Q2 2024, selling an estimated $123K and leaving 1,074 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.
Benjamin F. Edwards & Company first reported a position in ZBH in Q2 2013 and has held it in 45 quarters since. The position peaked at $361K in Q4 2017. 1,008 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.
- Benjamin F. Edwards & Company held 1,074 shares of Zimmer Biomet worth $117K as of Q2 2024.
- Benjamin F. Edwards & Company sold 1,045 Zimmer Biomet shares in Q2 2024, an estimated $123K.
- Zimmer Biomet made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1067 holding.
- Benjamin F. Edwards & Company first reported a position in Zimmer Biomet in Q2 2013 and has held it in 45 quarters since.
- Benjamin F. Edwards & Company's Zimmer Biomet position peaked at $361K in Q4 2017.
- 1,008 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.